Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.	age-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Recruiting	Not stated	2026-06-24		NCT06271330

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Nantes University Hospital	223
Rennes University Hospital	89

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ducloyer	Nantes	France	1

Clinical trials